Results 271 to 280 of about 513,632 (295)
Some of the next articles are maybe not open access.
Hepatitis C and autoreactivity
Digestive and Liver Disease, 2007After the discovery of HCV in 1989 a great amount of data has been produced in order to identify a possible aetiology for a number of idiopathic diseases, especially those with a suspected immune origin. Many associations have not been confirmed by prospective studies (as in the case of autoimmune hepatitis); other immune abnormalities, such as the ...
BIANCHI, FRANCESCO BIANCO+5 more
openaire +4 more sources
The oncologic burden of hepatitis C virus infection: A clinical perspective
Ca-A Cancer Journal for Clinicians, 2017Harrys A Torres+2 more
exaly
The importance of immunization in cancer prevention, treatment, and survivorship
Ca-A Cancer Journal for Clinicians, 2017Ted Gansler+2 more
exaly
Disparities in liver cancer occurrence in the United States by race/ethnicity and state
Ca-A Cancer Journal for Clinicians, 2017Farhad Islami+2 more
exaly
Cancer‐related risk factors and preventive measures in US Hispanics/Latinos
Ca-A Cancer Journal for Clinicians, 2012Priti Bandi
exaly
Therapeutic strategies for hepatitis B virus infection: towards a cure
Nature Reviews Drug Discovery, 2019Antonio Bertoletti+2 more
exaly
Hepatitis C therapeutics: current status and emerging strategies
Nature Reviews Drug Discovery, 2002Ding-wei Ye
exaly
Human occludin is a hepatitis C virus entry factor required for infection of mouse cells
Nature, 2009Alexander Ploss, Matthew J Evans
exaly
Hepatitis B virus X protein identifies the Smc5/6 complex as a host restriction factor
Nature, 2016Rudolf Beran+2 more
exaly